In this interview, the Managing Director of Cooper Metals (ASX:CPM) discusses the company's active drilling program in the Mount Isa region, targeting copper and gold prospects. They highlight their methodical approach to exploration, emphasizing the importance of ground truthing and geochemical/geophysical data in delineating robust drill targets. The interview also covers their "scout drilling campaign" and the anticipation of assay results. Cooper Metals' expansion into new tenements near the Eloise Deposit and plans for the future are highlighted, and their commitment to keeping stakeholders informed remains a key focus throughout the conversation.
Copyright 2023 – Finance News Network
20 Mar 2023 - Tony Brinker, Institutional Equity Research, Select Equities, discusses what happened with the Silicon Valley Bank, and implications for Australian investors.
03 Feb 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook provides an update on the company's record December quarter results, progress with strategic partners and overseas expansion plans.
30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
17 Nov 2022 - Genetic Signatures Limited (ASX:GSS) CEO and Director Dr John Melki discusses the company's technology, business model, 2022 highlights and outlook.
13 Apr 2023 - Newmark Capital Managing Director Chris Langford discusses the group's portfolio, investment philosophy, results, strategy, the recent share buyback, and the outlook for the REIT sector.
01 Sep 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook, discusses highlights from FY21, including growth in partners and transactions as the company's technology finds greater adoption and new markets.
23 Dec 2019 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO, James McBrayer talks about the company's joint venture to expand Positron Emission Tomography (PET) diagnostics business opportunities for NSW and Australia.
03 Dec 2019 - Noxopharm Limited (ASX:NOX) Executive Chairman & CEO, Dr Graham Kelly, discusses clinical results from the company's Phase 1b clinical DARRT-1 trial for its lead product candidate, Veyonda, with low-dose radiotherapy.
20 Sep 2024 - Prime Financial Group Limited (ASX:PFG) Managing Director, CEO and Chairman Simon Madder provides an update on the company, discussing drivers behind FY24 performance, the acquisitions of Altor Capital and Equity Plan Management, and outlook.
08 Mar 2024 - Dotz Nano's (ASX:DTZ) groundbreaking Dotz Earth Technology is revolutionizing carbon capture. CEO Sharon Malka shares insights on their recent bench-scale unit success and partnership with SINTEF, highlighting strides towards a carbon-neutral future
